Y
Yehuda Chowers
Researcher at Rambam Health Care Campus
Publications - 216
Citations - 16492
Yehuda Chowers is an academic researcher from Rambam Health Care Campus. The author has contributed to research in topics: Inflammatory bowel disease & Infliximab. The author has an hindex of 60, co-authored 211 publications receiving 14526 citations. Previous affiliations of Yehuda Chowers include University of California, San Diego & Tel Aviv University.
Papers
More filters
Journal ArticleDOI
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollón,Axel Dignass,Vito Annese,Herbert Tilg,Gert Van Assche,James O. Lindsay,Laurent Peyrin-Biroulet,Garret Cullen,Marco Daperno,Torsten Kucharzik,Florian Rieder,Sven Almer,Alessandro Armuzzi,Marcus Harbord,Jost Langhorst,Miquel Sans,Yehuda Chowers,Gionata Fiorino,Pascal Juillerat,Gerassimos J. Mantzaris,Fernando Rizzello,Stephan R. Vavricka,Paolo Gionchetti +22 more
TL;DR: The methodology of the consensus process, and the classification, diagnosis and medical management of active and quiescent Crohn’s disease of this ECCO Consensus are concerns.
Journal ArticleDOI
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Jean-François Rahier,Fernando Magro,Candida Abreu,Alessandro Armuzzi,Shomron Ben-Horin,Yehuda Chowers,Mario Cottone,L. de Ridder,Glen A. Doherty,Robert Ehehalt,Maria Esteve,K.H. Katsanos,Charlie W. Lees,Eithne MacMahon,Tom G. Moreels,Walter Reinisch,Herbert Tilg,Lydjie Tremblay,Gigi Veereman-Wauters,N. Viget,Yazdan Yazdanpanah,Rami Eliakim,Jean-Frederic Colombel +22 more
TL;DR: The treatment of inflammatory bowel disease has been revolutionised over the past decade by the increasing use of immunomodulators, mainly azathioprine/6-mercaptopurine and methotrexate, together with the advent of biological therapy.
Journal ArticleDOI
Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 1: Definitions and Diagnosis
Axel Dignass,Rami Eliakim,Fernando Magro,Christian Maaser,Yehuda Chowers,Karel Geboes,Gerassimos J. Mantzaris,Walter Reinisch,Jean-Frederic Colombel,Severine Vermeire,Simon Travis,James O. Lindsay,Gert Van Assche +12 more
TL;DR: The aim of the Consensus is to promote a European perspective on the management of ulcerative colitis and its dilemmas to avoid duplication of effort in the future.
Journal ArticleDOI
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
Spl Travis,Eduard F. Stange,Marc Lémann,Tom Øresland,Yehuda Chowers,Alastair Forbes,G. D'Haens,G Kitis,Antoine Cortot,Cosimo Prantera,P. Marteau,J-F Colombel,Paolo Gionchetti,Yoram Bouhnik,Emmanuel Tiret,J Kroesen,M Starlinger,Neil Mortensen +17 more
TL;DR: This second section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns treatment of active disease, maintenance of medically induced remission, and surgery.
Journal ArticleDOI
European evidence-based Consensus on the management of ulcerative colitis: Current management.
Simon Travis,Eduard F. Stange,Marc Lémann,Tom Øresland,W. A. Bemelman,Yehuda Chowers,Jean-Frederic Colombel,Geert R. D'Haens,Subrata Ghosh,P. Marteau,Wolfgang Kruis,N. J. Mcc Mortensen,Freddy Penninckx,Miquel A. Gassull +13 more
TL;DR: The most widely used index for severe UC is Truelove and Wi_tts as discussed by the authors, which is defined as any patient who has a bloody stool frequency ≥ 6/day and a tachycardia (> 90 bpm), or temperature > 37.8 °C, or anaemia (haemoglobin 30 mm/h) has severe ulcerative colitis.